Preparation process of human prothrombin compound
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 华润博雅生物制药集团股份有限公司
- Publication Date
- 2011-02-16
Abstract
Description
technical field
[0001] The invention relates to a preparation process of a human prothrombin complex, which belongs to the field of biopharmaceuticals. Background technique
[0002] The human prothrombin complex contains four coagulation factors II, VII, IX, and X that vitamin K depends on for its synthesis in the liver. Both vitamin K deficiency and severe liver disease can cause deficiency of these four factors. The lack of any of the above factors can lead to coagulation disorders. Infusion of human prothrombin complex can increase blood coagulation factor II, VII, IX, and X concentrations. Therefore, it is mainly used for the treatment of congenital and acquired coagulation factor II, VII, IX, and X deficiency. The standard preparation method is: take freshly separated liquid plasma and frozen plasma from healthy blood donors, use direct gel adsorption method or low-temperature ethanol and polyethylene glycol method to separate protein from plasma, and use nationally ...